BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10431154)

  • 61. Are lytic granules and perforin 1 involved in lysis induced by in vivo-primed peritoneal exudate cytolytic T lymphocytes?
    Berke G; Rosen D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):412-6. PubMed ID: 3493559
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential effects of cytolytic T cell subsets on intracellular infection.
    Stenger S; Mazzaccaro RJ; Uyemura K; Cho S; Barnes PF; Rosat JP; Sette A; Brenner MB; Porcelli SA; Bloom BR; Modlin RL
    Science; 1997 Jun; 276(5319):1684-7. PubMed ID: 9180075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.
    Müllbacher A; Wallich R; Moyer RW; Simon MM
    J Immunol; 1999 Jun; 162(12):7315-21. PubMed ID: 10358181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serine protease inhibitors and cytotoxic T lymphocytes.
    Ashton-Rickardt PG
    Immunol Rev; 2010 May; 235(1):147-58. PubMed ID: 20536561
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo.
    Spaeny-Dekking EH; Hanna WL; Wolbink AM; Wever PC; Kummer JA; Swaak AJ; Middeldorp JM; Huisman HG; Froelich CJ; Hack CE
    J Immunol; 1998 Apr; 160(7):3610-6. PubMed ID: 9531325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells.
    Griffiths GM; Mueller C
    Immunol Today; 1991 Nov; 12(11):415-9. PubMed ID: 1786074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Granzymes and apoptosis: targeting the cell cycle.
    Greenberg AH; Litchfield DW
    Curr Top Microbiol Immunol; 1995; 198():95-119. PubMed ID: 7774285
    [No Abstract]   [Full Text] [Related]  

  • 69. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
    Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
    J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells.
    Pardo J; Balkow S; Anel A; Simon MM
    Eur J Immunol; 2002 Jul; 32(7):1980-5. PubMed ID: 12115618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxic activity of the lymphocyte toxin granzyme B.
    Wowk ME; Trapani JA
    Microbes Infect; 2004 Jul; 6(8):752-8. PubMed ID: 15207822
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
    J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
    Trapani JA; Smyth MJ
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes).
    Winkler U; Allison NJ; Woodard SL; Gault RA; Ewoldt GR; Kam CM; Abuelyaman A; Powers JC; Hudig D
    Mol Immunol; 1996; 33(7-8):615-23. PubMed ID: 8760273
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells.
    Dick T; Reichmann G; Ebnet K; Simon MM; Dienes HP; Echternacher B; Krammer PH; Reske-Kunz AB
    Cell Immunol; 1993 Dec; 152(2):333-47. PubMed ID: 8258142
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Orphan granzymes find a home.
    Bovenschen N; Kummer JA
    Immunol Rev; 2010 May; 235(1):117-27. PubMed ID: 20536559
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How to induce involuntary suicide: the need for dipeptidyl peptidase I.
    Podack ER
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8312-4. PubMed ID: 10411865
    [No Abstract]   [Full Text] [Related]  

  • 80. Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity.
    Talento A; Nguyen M; Law S; Wu JK; Poe M; Blake JT; Patel M; Wu TJ; Manyak CL; Silberklang M
    J Immunol; 1992 Dec; 149(12):4009-15. PubMed ID: 1460287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.